Tingshi Su
Papers
1
Total Citations
9
H-Index
1
About
Tingshi Su is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC). Her most-cited work, a 2017 multi-institutional study analyzing the safety of robotic SBRT for HCC patients, has garnered 9 citations and remains a foundational reference in the field. In this pivotal study, Su investigated the factors affecting treatment safety in 74 patients with Child–Turcotte–Pugh Class A cirrhosis, providing critical insights into how robotic SBRT can be delivered with minimal toxicity. Her contributions have helped refine patient selection criteria and dose constraints, directly improving clinical outcomes for liver cancer patients. By bridging the gap between advanced radiotherapy technology and real-world patient safety, Su’s research has influenced practice guidelines and inspired further investigation into risk-adapted treatment planning. Her work exemplifies the rigorous, patient-centered approach needed to advance oncologic care, making her a respected voice in the radiation oncology community.
Research Focus
Key Achievements
Top Papers
- 1